Endorectal Balloon Market
Endorectal Balloon Market Study by Use in Hospitals, Clinics, and Radiotherapy Centers From 2024 to 2034
Analysis of Endorectal Balloon Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Endorectal Balloon Market Outlook (2024 to 2034)
Expanding at a CAGR of 9.9%, the global endorectal balloon market is projected to increase from a valuation of US$ 222.27 million in 2024 to US$ 570.06 million by 2034.
Endorectal balloons are specialized medical devices that are used in radiation therapy for prostate cancer to stabilize the prostate gland while limiting radiation exposure to other healthy tissues, such as the bladder and rectum.
To minimize radiation-induced adverse effects and enable accurate targeting of the prostate tumor, these balloons are introduced into the rectum and inflated with air or water to generate a cushioning effect. During prostate cancer radiation therapy, endorectal balloons are essential for enhancing patient comfort and treatment results.
The market for endorectal balloons has grown steadily in recent years due to reasons such as rising prostate cancer prevalence, improvements in radiation therapy technology, and rising awareness of the significance of organ motion management. Endorectal balloons are essential for lowering rectal toxicity and enhancing treatment precision during radiation therapy for prostate cancer, which improves patient results and quality of life.
In addition to considering patient comfort, the IsoLoc Endorectal Balloon's design streamlines three difficult clinical situations that many doctors encounter while administering radiation treatment to the prostate or in connection with it. Initially, for those who are gaseous, its gas-release tip eliminates rectal gas and lessens prostate motion.
Second, the ERB's shape helps define the anatomy in challenging planning scenarios involving patients who have had radiation therapy.3. Third, in individuals whose intestine is low-lying, the IsoLoc Endorectal Balloon raises and repositions the colon.
| Report Attributes | Details |
|---|---|
| Endorectal Balloon Market Size (2024E) | US$ 222.27 Million |
| Forecasted Market Value (2034F) | US$ 570.06 Million |
| Global Market Growth Rate (2024 to 2034) | 9.9% CAGR |
| Western Europe Market Growth Rate (2024 to 2034) | 5.6% CAGR |
| East Asia Market Share (2034F) | 9.2% |
| Hospitals Segment Value (2034F) | US$ 272.77 Million |
| South Korea Market Value (2034F) | US$ 22.89 Million |
| Key Companies Profiled | Bionix; AngioDynamics; QLRAD; Civco Medical Solutions; Qfix; Boston Scientific Corporation; Varian Medical Systems Inc.; Elekta AB; Medtronic plc; Bionix Radiation Therapy; Best Medical International Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Endorectal Balloon Market Witnessing Growth for Clinical Advantages
The increasing use of an endorectal balloon in the healthcare sector is fueled by the advantages provided by the endorectal balloon for better inflation and deflation control and greater visibility.
The endorectal balloon market is therefore subjected to witness overwhelming growth owing to the need for providing improved clinical assistance for patients and the growing application of medical devices to ease the process of treatments and cater to the need for radiotherapy.
Market Players to Leverage the Increasing Demand for Endorectal Balloon
As the endorectal balloon application includes numerous advantages, which include stabilizing the prostate gland and rectum during daily treatment, major market players such as Bionix and QLRAD are focusing on introducing an improved endorectal balloon for providing ease to patients while they undergo treatments, helping them gain a competitive edge with greater accuracy and enhanced simplicity.
Furthermore, medical device manufacturers today are seen collaborating and getting involved in strategic partnerships for the effective commercialization of their next-generation products, which include the endorectal balloon exclusively for radiotherapy and prostate cancer treatment. These developments are expected to nurture the endorectal balloon market with changing clinical requirements.
The endorectal balloon is a single-use, inflatable, disposable, non-powered rectal device used in the immobilization of prostate in patients. These devices are intended to be used in patients undergoing radiotherapy and it is used in all stages. The endorectal balloon is traditionally used in the treatment of prostate cancer with benefits like consistent rectal filing & prostate stability.
The endorectal balloon is used to move the posterior wall away from the prostate and helps in the reduction of radiation to the rectum and mucosal wall. It is well tolerated in over 95% of patients. While, they are contraindicated in patients with severe hemorrhoids, anal fissures, peri-rectal/peri-anal abscess, rectal fistula, anal canal stricture, and prior low anterior resection.
When it comes to technical information, the endorectal balloon contains two radiopaque markers and they are located in the catheter shaft. It is equipped with a valve and it controls inflation and deflation. Advantages of the endorectal balloon include infra-fraction motion control, limited radiation dose to the wall; control of late toxicity, increased visibility, and increased patient compliance.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Endorectal Balloon Market: Drivers and Restraints
Increasing demand for intensity-modulated radiotherapy by decreasing toxicity of the rectum accelerates the growth of the endorectal balloon market. Prostate infraction motion is the major concern in radiotherapy, regardless of the type of therapy.
Typically, prostate motion is associated with rectal fillings and bladder function. Along with this, the advancement of technologies enabled the usage of proton therapy for prostate cancer treatment. It allows dose distribution to the target area and controls the dose escalation.
Dose escalation of a dose is also associated with toxicities. To avoid dose escalations in proton therapies, the endorectal balloon is used to control the dose escalations, and prostate movement and increases the rectal filling without disturbing normal physiological functions. The endorectal balloon is used to improve the target localization and decrease anorectal toxicities.
Emerging evidence of endorectal balloon advantages in reducing toxicities is expected to boost the growth of the market. All these factors fueled the burgeoning growth of the endorectal balloon market. Further, the advantages of the endorectal balloon over the conventional methods accelerated the growth of the market.
The lack of substantial evidence regarding the benefits of the endorectal balloon in the large patient pool has limited the growth of the endorectal balloon market.
Endorectal Balloon Market: Market Overview
The global endorectal balloon market has witnessed robust growth due to increasing demand for devices. They are more advantageous over conventional methods in treating prostate cancer. It controls dose escalations and reduces rectum toxicity. The Endorectal Balloon market has a presence of a few players, which have a huge market share in the global market operating at the country level.
There are huge opportunities for untapped markets across the world due to the potential benefits of endorectal balloons. The key players in the Endorectal Balloon market are mainly focused on R&D to accelerate the development due to a limited number of manufacturers. The future of the Endorectal Balloon market is anticipated to double CAGR during the forecasting period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Endorectal Balloon Market: Region-wise Overview
The global endorectal balloon market is segmented into the following regions - North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, and the Middle East & Africa.
North America is dominant in the global endorectal balloon market mainly due to the increasing prevalence of prostate cancer. In North America, particularly the USA is dominating due to high adoption among end users. Economic conditions in the APAC region are driving the endorectal balloon market to new heights.
Europe and APAC endorectal balloon markets are the fastest growing regions due to increasing awareness. Growth in the Middle East and African region is considerably less when compared to the other regions. However, North America would maintain its position in the endorectal balloon market, though; we are anticipating developed economies such as Australia to have the highest growth rate in the endorectal balloon market.
Endorectal Balloon Market: Key Participants
The key participants in the endorectal balloon Market are QLRAD, Bionix, and others. The companies are mainly focusing on collaborations and partnerships to keep up the pace of the competition and to develop new products.
The report covers an exhaustive analysis on
- Market Segments
- Market Dynamics
- Historical Actual Market Size, 2019 to 2023
- Market Size & Forecast, 2024 to 2034
- Supply & Demand Value Chain
- Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
- Aircraft Refurbishing Market Drivers and Restraints
Regional analysis for the Market includes
- North America
- Latin America
- Europe
- Asia Pacific & Japan
- Middle East & Africa
Report Highlights
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size, recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Segmentation of the Endorectal Balloon Market Research
-
By End User :
- Hospitals
- Clinics
- Radiotherapy Centers
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 7. Global Market Analysis and Forecast, By End User
- 7.1. Hospitals
- 7.2. Clinics
- 7.3. Radiotherapy Centers
- 8. Global Market Analysis and Forecast, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Western Europe
- 8.4. Eastern Europe
- 8.5. East Asia
- 8.6. South Asia & Pacific
- 8.7. MEA
- 9. North America Sales Analysis and Forecast, by Key Segments and Countries
- 10. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 11. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 12. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 13. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 14. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 15. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 16. Sales Forecast by End User for 30 Countries
- 17. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 18. Company Profile
- 18.1. Civco Medical Solutions
- 18.2. Medical Intelligence
- 18.3. Philips Healthcare
- 18.4. Radiological Imaging Technologies
- 18.5. Medtronic
- 18.6. Bard Peripheral Vascular
- 18.7. Elekta
- 18.8. Iradimed Corporation
- 18.9. Varian Medical Systems
- 18.10. Qfix
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by End User
Table 3: North America Market US$ Mn Forecast by Country
Table 4: North America Market US$ Mn Forecast by End User
Table 5: Latin America Market US$ Mn Forecast by Country
Table 6: Latin America Market US$ Mn Forecast by End User
Table 7: Western Europe Market US$ Mn Forecast by Country
Table 8: Western Europe Market US$ Mn Forecast by End User
Table 9: Eastern Europe Market US$ Mn Forecast by Country
Table 10: Eastern Europe Market US$ Mn Forecast by End User
Table 11: East Asia Market US$ Mn Forecast by Country
Table 12: East Asia Market US$ Mn Forecast by End User
Table 13: South Asia & Pacific Market US$ Mn Forecast by Country
Table 14: South Asia & Pacific Market US$ Mn Forecast by End User
Table 15: MEA Market US$ Mn Forecast by Country
Table 16: MEA Market US$ Mn Forecast by End User
Table 17: Latin America Market US$ Mn Forecast by Country
Table 18: Latin America Market US$ Mn Forecast by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 3: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 4: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 5: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 6: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 7: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 8: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 10: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 11: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 14: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 15: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 16: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 18: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What are the key industry trends of the global endorectal balloon devices market?
Endorectal balloon market players leveraging opportunities created with growing product demand.
Which segment has the largest share in the endorectal balloon market?
The hospitals segment has the largest share of the global market.
Endorectal Balloon Market